Oct 15, 2026 07:31AM
Oct 15, 2026 07:30AM
Aug 13, 2026 08:30AM
Jul 8, 2026 07:02AM
Jul 8, 2026 07:00AM
May 12, 2026 07:00AM
Jun 25, 2025 08:02AM Ovid Therapeutics (OVID) Enters Agreement with Immedica Pharma AB for Sale of Future Ganaxolone Royalties
Jun 25, 2025 08:00AM
Aug 6, 2024 04:01PM
Apr 8, 2022 08:00AM
Mar 15, 2022 08:00AM
Mar 4, 2022 08:00AM
Feb 8, 2022 08:03AM
Feb 8, 2022 08:00AM Healx and Ovid Therapeutics to Enter Strategic Partnership
Jan 3, 2022 06:40AM
Jan 3, 2022 06:30AM
Nov 10, 2021 08:30AM
Jun 4, 2021 08:01AM
Jun 4, 2021 08:00AM
May 26, 2021 08:19AM
May 26, 2021 08:00AM Ovid Therapeutics Appoints Dr. Joy A. Cavagnaro and Dr. Bruce A. Sullenger to its Scientific Advisory Board
May 13, 2021 04:05PM
May 12, 2021 08:00AM
Apr 20, 2021 08:00AM
Apr 19, 2021 08:21AM
Apr 19, 2021 08:00AM
Mar 30, 2021 08:00AM
Mar 15, 2021 08:00AM Ovid Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results, Provides Corporate Update for 2021
Mar 3, 2021 07:05AM
Mar 3, 2021 07:00AM
Dec 2, 2020 09:28AM
Aug 25, 2020 07:14AM
Aug 25, 2020 07:04AM
Aug 25, 2020 07:00AM
Aug 25, 2020 07:00AM Phase 2 ELEKTRA Study of Soticlestat (TAK-935/OV935) Meets Primary Endpoint Reducing Seizure Frequency in Children with Dravet Syndrome or Lennox-Gastaut Syndrome
Aug 6, 2018 09:27AM

1,201,783 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All